How much revenue did Eisai Co generate this year?
Eisai Co has achieved a revenue of 741.75 B JPY this year.
Eisai Co Revenue 2024
Eisai Co Revenue
741.75 B JPY
Ticker
4523.T
ISIN
JP3160400002
WKN
855526
In 2024, Eisai Co's sales reached 741.75 B JPY, a -0.36% difference from the 744.4 B JPY sales recorded in the previous year.
The Eisai Co Revenue history
| YEAR | REVENUE (undefined JPY) | GROSS MARGIN (%) |
|---|---|---|
| 2027e | 921.32 | 63,65 |
| 2026e | 852.85 | 68,76 |
| 2025e | 773.93 | 75,77 |
| 2024 | 741.75 | 79,06 |
| 2023 | 744.4 | 76,12 |
| 2022 | 756.23 | 78,10 |
| 2021 | 645.94 | 75,04 |
| 2020 | 695.62 | 75,91 |
| 2019 | 642.83 | 71,34 |
| 2018 | 600.05 | 66,48 |
| 2017 | 539.1 | 63,73 |
| 2016 | 547.92 | 64,60 |
| 2015 | 548.47 | 64,70 |
| 2014 | 600.36 | 68,66 |
| 2013 | 573.66 | 69,65 |
| 2012 | 647.98 | 73,25 |
| 2011 | 768.91 | 78,18 |
| 2010 | 803.15 | 79,99 |
| 2009 | 781.74 | 80,50 |
| 2008 | 734.29 | 83,80 |
| 2007 | 674.11 | 83,78 |
| 2006 | 601.25 | 82,54 |
| 2005 | 533.01 | 81,43 |
Eisai Co Revenue, EBIT, Net Income JP3160400002 · 855526
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Eisai Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eisai Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eisai Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Eisai Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Eisai Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Eisai Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eisai Co’s growth potential.
Eisai Co Revenue, EBIT and net profit per share
| Date | Eisai Co Revenue | Eisai Co EBIT | Eisai Co Net Income |
|---|---|---|---|
| 2027e | 921.32 B undefined | 89.06 B undefined | 78.36 B undefined |
| 2026e | 852.85 B undefined | 71.21 B undefined | 62.87 B undefined |
| 2025e | 773.93 B undefined | 60.1 B undefined | 46.02 B undefined |
| 2024 | 741.75 B undefined | 46.48 B undefined | 42.41 B undefined |
| 2023 | 744.4 B undefined | 40.44 B undefined | 55.43 B undefined |
| 2022 | 756.23 B undefined | 53.86 B undefined | 47.95 B undefined |
| 2021 | 645.94 B undefined | 53.02 B undefined | 41.94 B undefined |
| 2020 | 695.62 B undefined | 136.23 B undefined | 121.77 B undefined |
| 2019 | 642.83 B undefined | 93.32 B undefined | 63.39 B undefined |
| 2018 | 600.05 B undefined | 76.18 B undefined | 51.85 B undefined |
| 2017 | 539.1 B undefined | 60.81 B undefined | 39.36 B undefined |
| 2016 | 547.92 B undefined | 55.27 B undefined | 54.93 B undefined |
| 2015 | 548.47 B undefined | 28.6 B undefined | 43.25 B undefined |
| 2014 | 600.36 B undefined | 71.11 B undefined | 32.96 B undefined |
| 2013 | 573.66 B undefined | 70.46 B undefined | 48.28 B undefined |
| 2012 | 647.98 B undefined | 95.75 B undefined | 58.51 B undefined |
| 2011 | 768.91 B undefined | 113.12 B undefined | 67.39 B undefined |
| 2010 | 803.15 B undefined | 86.41 B undefined | 40.34 B undefined |
| 2009 | 781.74 B undefined | 91.81 B undefined | 47.68 B undefined |
| 2008 | 734.29 B undefined | 17.76 B undefined | -17.01 B undefined |
| 2007 | 674.11 B undefined | 105.27 B undefined | 70.61 B undefined |
| 2006 | 601.25 B undefined | 95.16 B undefined | 63.41 B undefined |
| 2005 | 533.01 B undefined | 86.4 B undefined | 55.51 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 533.01 B JPY | 86.4 B JPY | 55.51 B JPY |
| 2006 | 601.25 B JPY | 95.16 B JPY | 63.41 B JPY |
| 2007 | 674.11 B JPY | 105.27 B JPY | 70.61 B JPY |
| 2008 | 734.29 B JPY | 17.76 B JPY | -17.01 B JPY |
| 2009 | 781.74 B JPY | 91.81 B JPY | 47.68 B JPY |
| 2010 | 803.15 B JPY | 86.41 B JPY | 40.34 B JPY |
| 2011 | 768.91 B JPY | 113.12 B JPY | 67.39 B JPY |
| 2012 | 647.98 B JPY | 95.75 B JPY | 58.51 B JPY |
| 2013 | 573.66 B JPY | 70.46 B JPY | 48.28 B JPY |
| 2014 | 600.36 B JPY | 71.11 B JPY | 32.96 B JPY |
| 2015 | 548.47 B JPY | 28.6 B JPY | 43.25 B JPY |
| 2016 | 547.92 B JPY | 55.27 B JPY | 54.93 B JPY |
| 2017 | 539.1 B JPY | 60.81 B JPY | 39.36 B JPY |
| 2018 | 600.05 B JPY | 76.18 B JPY | 51.85 B JPY |
| 2019 | 642.83 B JPY | 93.32 B JPY | 63.39 B JPY |
| 2020 | 695.62 B JPY | 136.23 B JPY | 121.77 B JPY |
| 2021 | 645.94 B JPY | 53.02 B JPY | 41.94 B JPY |
| 2022 | 756.23 B JPY | 53.86 B JPY | 47.95 B JPY |
| 2023 | 744.4 B JPY | 40.44 B JPY | 55.43 B JPY |
| 2024 | 741.75 B JPY | 46.48 B JPY | 42.41 B JPY |
| 2025e | 773.93 B JPY | 60.1 B JPY | 46.02 B JPY |
| 2026e | 852.85 B JPY | 71.21 B JPY | 62.87 B JPY |
| 2027e | 921.32 B JPY | 89.06 B JPY | 78.36 B JPY |
Eisai Co stock margins JP3160400002 · 855526
The Eisai Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eisai Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eisai Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Eisai Co's sales revenue. A higher gross margin percentage indicates that the Eisai Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Eisai Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Eisai Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eisai Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eisai Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eisai Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Eisai Co Margin History
| Eisai Co Gross margin | Eisai Co Profit margin | Eisai Co EBIT margin | Eisai Co Profit margin |
|---|---|---|---|
| 2027e | 79.06 % | 9.67 % | 8.5 % |
| 2026e | 79.06 % | 8.35 % | 7.37 % |
| 2025e | 79.06 % | 7.77 % | 5.95 % |
| 2024 | 79.06 % | 6.27 % | 5.72 % |
| 2023 | 76.12 % | 5.43 % | 7.45 % |
| 2022 | 78.1 % | 7.12 % | 6.34 % |
| 2021 | 75.04 % | 8.21 % | 6.49 % |
| 2020 | 75.91 % | 19.58 % | 17.5 % |
| 2019 | 71.34 % | 14.52 % | 9.86 % |
| 2018 | 66.48 % | 12.7 % | 8.64 % |
| 2017 | 63.73 % | 11.28 % | 7.3 % |
| 2016 | 64.6 % | 10.09 % | 10.03 % |
| 2015 | 64.7 % | 5.21 % | 7.89 % |
| 2014 | 68.66 % | 11.84 % | 5.49 % |
| 2013 | 69.65 % | 12.28 % | 8.42 % |
| 2012 | 73.25 % | 14.78 % | 9.03 % |
| 2011 | 78.18 % | 14.71 % | 8.76 % |
| 2010 | 79.99 % | 10.76 % | 5.02 % |
| 2009 | 80.5 % | 11.74 % | 6.1 % |
| 2008 | 83.8 % | 2.42 % | -2.32 % |
| 2007 | 83.78 % | 15.62 % | 10.48 % |
| 2006 | 82.54 % | 15.83 % | 10.55 % |
| 2005 | 81.43 % | 16.21 % | 10.41 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 81.43 % | 16.21 % | 10.41 % |
| 2006 | 82.54 % | 15.83 % | 10.55 % |
| 2007 | 83.78 % | 15.62 % | 10.48 % |
| 2008 | 83.8 % | 2.42 % | -2.32 % |
| 2009 | 80.5 % | 11.74 % | 6.1 % |
| 2010 | 79.99 % | 10.76 % | 5.02 % |
| 2011 | 78.18 % | 14.71 % | 8.76 % |
| 2012 | 73.25 % | 14.78 % | 9.03 % |
| 2013 | 69.65 % | 12.28 % | 8.42 % |
| 2014 | 68.66 % | 11.84 % | 5.49 % |
| 2015 | 64.7 % | 5.21 % | 7.89 % |
| 2016 | 64.6 % | 10.09 % | 10.03 % |
| 2017 | 63.73 % | 11.28 % | 7.3 % |
| 2018 | 66.48 % | 12.7 % | 8.64 % |
| 2019 | 71.34 % | 14.52 % | 9.86 % |
| 2020 | 75.91 % | 19.58 % | 17.5 % |
| 2021 | 75.04 % | 8.21 % | 6.49 % |
| 2022 | 78.1 % | 7.12 % | 6.34 % |
| 2023 | 76.12 % | 5.43 % | 7.45 % |
| 2024 | 79.06 % | 6.27 % | 5.72 % |
| 2025e | 79.06 % | 7.77 % | 5.95 % |
| 2026e | 79.06 % | 8.35 % | 7.37 % |
| 2027e | 79.06 % | 9.67 % | 8.5 % |
Eisai Co Aktienanalyse
What does Eisai Co do?
Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Eisai Co's Sales Figures
The sales figures of Eisai Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Eisai Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Eisai Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Eisai Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Eisai Co stock
How much was the turnover of the company Eisai Co compared to the previous year?
The revenue of Eisai Co has increased by -0.36% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Eisai Co?
The revenue of Eisai Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Eisai Co measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Eisai Co so important for investors?
The revenue of Eisai Co is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Eisai Co pay?
Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 3.62 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.
What is the dividend yield of Eisai Co?
The current dividend yield of Eisai Co is 3.62 %.
When does Eisai Co pay dividends?
Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Eisai Co?
Eisai Co paid dividends every year for the past 23 years.
What is the dividend of Eisai Co?
For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 3.64 %.
In which sector is Eisai Co located?
Eisai Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Eisai Co from 12/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Eisai Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Eisai Co in the year 2023?
In the year 2023, Eisai Co distributed 160 JPY as dividends.
In which currency does Eisai Co pay out the dividend?
The dividends of Eisai Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Eisai Co
Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
